Supplement
Vitamin K is a fat-soluble vitamin that helps the body activate proteins needed for blood clotting and for binding calcium into bone. People mainly look at it for newborn nutritional support, where the evidence is strong, and for bone health, where reviews of trials found bone density improved. The size of that benefit was moderate, though, and inflammation markers, blood pressure and bruising showed no clear difference in small studies.
Sources: PMID 21674202; PMID 31076817
- Updated
- How we grade
- 35 studies cited
- Best evidence
- Grade B
- Conditions studied
- 13
- Outcomes
- 78
- Graded outcomes
- 0408
Evidence by condition
- Strong
- Moderate
- Limited
- Very limited
Menopause
- Bone Mineral Density: improves
- Weight: improves
- Estrogen: changes; see studies
Liver Cancer
- Cancer Mortality: improves
- Liver Cancer Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cancer Mortality Small Improvement | Improves (the measure goes down) | Small effect | 1,980 people | |||
| Liver Cancer Risk | Changes; see studies | 3 studies | 1,980 people | |||
Studies that measured liver cancer risk
| ||||||
Skin Health
- Bruising
- Erythema: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bruising No effect | NoneNo effect | 2 studies | 54 people | |||
| Erythema | Improves (the measure goes up) | 2 studies | 40 people | |||
Surgical Recovery
- Bruising
- Erythema: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bruising No effect | NoneNo effect | 2 studies | 10 people | |||
| Erythema | Improves (the measure goes up) | 2 studies | 20 people | |||
Cardiovascular Disease
- Blood Pressure
- Osteocalcin: improves
- Calcium Score: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Pressure No effect | NoneNo effect | 1 study | 60 people | |||
Studies that measured blood pressure | ||||||
| Osteocalcin | Improves (the measure goes up) | 1 study | 733 people | |||
| Calcium Score | Improves (the measure goes up) | 733 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 60 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 60 people | ||||
| Pulse Wave Velocity | Improves (the measure goes down) | 733 people | ||||
| Total cholesterol | Improves (the measure goes down) | 60 people | ||||
| Triglycerides | Improves (the measure goes down) | 60 people | ||||
Metabolic Health
- Adiponectin
- Insulin Resistance: improves
- Weight: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin No effect | NoneNo effect | 42 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 2 studies | 1,548 people | |||
| Weight | Improves (the measure goes down) | 2 studies | 1,548 people | |||
Studies that measured weight | ||||||
| Blood glucose | Improves (the measure goes down) | 1 study | 1,548 people | |||
Studies that measured blood glucose | ||||||
| Blood Pressure | Improves (the measure goes down) | 1 study | 1,548 people | |||
Studies that measured blood pressure | ||||||
| Insulin | Changes; see studies | 1 study | 1,548 people | |||
| Body Fat | Improves (the measure goes down) | 439 people | ||||
| Body Mass Index (BMI) | Improves (the measure goes down) | 1,548 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 421 people | ||||
| Glycemic Control | Improves (the measure goes up) | 42 people | ||||
| HbA1c | Improves (the measure goes down) | 1,548 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 421 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 1,548 people | ||||
| Osteoprotegerin | Improves (the measure goes up) | 379 people | ||||
| Total cholesterol | Improves (the measure goes down) | 1,548 people | ||||
| Triglycerides | Improves (the measure goes down) | 1,548 people | ||||
| Waist circumference | Improves (the measure goes down) | 439 people | ||||
Type 2 Diabetes
- Adiponectin
- Insulin Resistance: improves
- Blood glucose: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin No effect | NoneNo effect | 452 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 2 studies | 452 people | |||
| Blood glucose | Improves (the measure goes down) | 1 study | 452 people | |||
Studies that measured blood glucose | ||||||
| Insulin | Changes; see studies | 1 study | 452 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 452 people | ||||
| Glycemic Control | Improves (the measure goes up) | 533 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 452 people | ||||
| Leptin | Improves (the measure goes up) | 452 people | ||||
General Cardiovascular Health
- Adiponectin
- Insulin Resistance: improves
- Weight: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin No effect | NoneNo effect | 452 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 2 studies | 452 people | |||
| Weight | Improves (the measure goes down) | 2 studies | 1,548 people | |||
Studies that measured weight | ||||||
| Blood glucose | Improves (the measure goes down) | 1 study | 452 people | |||
Studies that measured blood glucose | ||||||
| Blood Pressure | Improves (the measure goes down) | 1 study | 60 people | |||
Studies that measured blood pressure | ||||||
| Insulin | Changes; see studies | 1 study | 452 people | |||
| Body Mass Index (BMI) | Improves (the measure goes down) | 1,548 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 452 people | ||||
| HbA1c | Improves (the measure goes down) | 1,548 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 60 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 452 people | ||||
| Leptin | Improves (the measure goes up) | 452 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 60 people | ||||
| Total cholesterol | Improves (the measure goes down) | 60 people | ||||
| Triglycerides | Improves (the measure goes down) | 60 people | ||||
Chronic Kidney Disease (CKD)
- Calcium Score
- Osteocalcin: improves
- Pulse Wave Velocity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Calcium Score No effect | NoneNo effect | 733 people | ||||
| Osteocalcin | Improves (the measure goes up) | 1 study | 733 people | |||
| Pulse Wave Velocity | Improves (the measure goes down) | 733 people | ||||
Osteopenia
- Bone Mineral Density: improves
Telangiectasia (Spider Veins)
- Erythema: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Erythema | Improves (the measure goes up) | 2 studies | 20 people |
What the published studies found
1 automated reading
LDL cholesterol
The best available review (2019, 13 studies) found little or no difference in LDL cholesterol. That review studied healthy or high cardiovascular risk individuals. 4 of the 5 studies read agree; 1 found an improvement. The evidence is moderate.
5 studies counted of 9 read: 1 review and 4 trials (180 people in the trials).
- Meta-analysis, 2019; 13 studies; healthy or high cardiovascular risk individuals: no clear difference (the review the verdict rests on).
no significant effects of vitamin K supplementation were found in case of
Effect of Vitamin K Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis - Randomised trial, 2026; 46 people; young adults with overweight or obesity: improves. Vitamin K2 Supplementation Reduces Cardiometabolic Risk Factors in Young Adults with Overweight and Obesity-A Randomized Placebo-Controlled Trial
- Randomised trial, 2020; 45 people; patients with type 2 diabetes: no clear difference.
LDL-C, HDL-C and LDL-C/HDL-C) did not change significantly
Effects of MK-7 Supplementation on Glycemic Status, Anthropometric Indices and Lipid Profile in Patients with Type 2 Diabetes: A Randomized Controlled Trial - Randomised trial, 2015; 58 people; women with rheumatoid arthritis: no clear difference.
no significant changes in lipid related markers
Effects of phylloquinone supplementation on lipid profile in women with rheumatoid arthritis: a double blind placebo controlled study - Crossover trial, 2008; 31 people; postmenopausal women: no clear difference.
total cholesterol and LDL-C were unaffected
Six weeks phylloquinone supplementation produces undesirable effects on blood lipids with no changes in inflammatory and fibrinolytic markers in postmenopausal women
- Meta-analysis, 2019; 13 studies; healthy or high cardiovascular risk individuals: no clear difference (the review the verdict rests on).
Key findings
- Bone Mineral DensityImproves (the measure goes up)
- Cancer MortalityImproves (the measure goes down)
- Bruising
Shop the evidence-backed picks
The collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
Or shop one supplement
Third-party tested Vitamin K products, in the forms the graded studies used where we can match them.
- Grade B
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
Studies cited
35 studies from PubMed
- Effect of vitamin K on bone mineral density: a meta-analysis of randomized controlled trials
- A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women a comparative study with vitamin D3 and estrogen-progestin therapy
- Factors affecting bone loss in female endurance athletes: a two-year follow-up study
- Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women
- Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women
- Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women
- Effect of vitamin K supplementation on bone loss in elderly men and women
- Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women
- Vitamin K, circulating cytokines, and bone mineral density in older men and women
- Effect of continuous combined therapy with vitamin K(2) and vitamin D(3) on bone mineral density and coagulofibrinolysis function in postmenopausal women
- Randomized pilot trial of vitamin K2 for bone loss in patients with primary biliary cirrhosis
- Effect of vitamin K on bone mineral density and fractures in adults: an updated systematic review and meta-analysis of randomised controlled trials.
- Effect of Vitamin K on Bone Mineral Density and Fracture Risk in Adults: Systematic Review and Meta-Analysis.
- The Efficacy of Vitamin K, A Member Of Naphthoquinones in the Treatment of Cancer: A Systematic Review and Meta-Analysis
- Effect of menatetrenone, a vitamin k2 analog, on recurrence of hepatocellular carcinoma after surgical resection: a prospective randomized controlled trial
- The effect of menatetrenone, a vitamin K2 analog, on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment: a pilot study
- Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis
- Effects of vitamin K supplementation on bone mineral density at different sites and bone metabolism in the middle-aged and elderly population.
- Dietary vitamin K2 supplement improves bone status after lung and heart transplantation
- Vitamin K2 treatment for postmenopausal osteoporosis in Indonesia
- Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG)
- Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age
- Time-dependent effects of vitamin K2 (menatetrenone) on bone metabolism in postmenopausal women
- The effect of vitamin K supplementation on cardiovascular risk factors: a systematic review and meta-analysis.
- Effect of Menaquinone-7 (MK-7) Supplementation on Anthropometric Measurements, Glycemic Indices, and Lipid Profiles: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Possible effects of one week vitamin K (menaquinone-4) tablets intake on glucose tolerance in healthy young male volunteers with different descarboxy prothrombin levels
- Effects of topical vitamin K and retinol on laser-induced purpura on nonlesional skin
- The role of topical vitamin K oxide gel in the resolution of postprocedural purpura
- The effects of topical vitamin K on bruising after laser treatment
- Lack of the effect of topical vitamin K on bruising after mechanical injury
- Vitamin K for the primary prevention of cardiovascular disease
- Effect of vitamin K supplementation on insulin sensitivity: a meta-analysis.
- Effects of vitamin K supplementation on vascular calcification in chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials.
- Effect of Vitamin K Supplementation on Glycemic Control: A Systematic Review and Meta-Analysis of Clinical Trials.
- The relationship between vitamin K and T2DM: a systematic review and meta-analysis.